A Study of Radiation With Sorafenib in Advanced Cancer

Summary

The purpose of this study is to test the combination of radiation treatment and an anti-angiogenic drug called sorafenib (or BAY 43-9006 or Nexavar) to determine the effects of this combination on cancers but also on side effects of radiation treatment. This study will also determine the highest safe dose of sorafenib that can be given with radiation treatment.

Timeline

Start

2007-05

Primary completion

2010-12

Completion

2011-05

Drugs

Indications